Polygenic Score (PGS) ID: PGS000776

Predicted Trait
Reported Trait Cirrhosis
Mapped Trait(s) cirrhosis of liver (EFO_0001422)
Released in PGS Catalog: May 28, 2021
Download Score FTP directory
Terms and Licenses
PGS obtained from the Catalog should be cited appropriately, and used in accordance with any licensing restrictions set by the authors. See EBI Terms of Use (https://www.ebi.ac.uk/about/terms-of-use/) for additional details.

Score Details

Score Construction
PGS Name GRS9_Cirr
Development Method
Name Variants significantly associated with alcohol-related cirrhosis
Parameters FDR < 20%
Variants
Original Genome Build NR
Number of Variants 9
Effect Weight Type beta
PGS Source
PGS Catalog Publication (PGP) ID PGP000180
Citation (link to publication) Innes H et al. Gastroenterology (2020)
Ancestry Distribution
Source of Variant
Associations (GWAS)
European: 100%
168,430 individuals (100%)
Score Development/Training
European: 100%
4,613 individuals (100%)
PGS Evaluation
Not Reported: 100%
1 Sample Sets

Development Samples

Source of Variant Associations (GWAS)
Study Identifiers Sample Numbers Sample Ancestry Cohort(s)
GWAS Catalog: GCST90011734
Europe PMC: 32561361
33,437 individuals European UKB
GWAS Catalog: GCST90011735
Europe PMC: 32561361
33,330 individuals European UKB
GWAS Catalog: GCST90011736
Europe PMC: 32561361
33,324 individuals European UKB
GWAS Catalog: GCST90011737
Europe PMC: 32561361
34,101 individuals European UKB
GWAS Catalog: GCST90011738
Europe PMC: 32561361
34,238 individuals European UKB
Score Development/Training
Study Identifiers Sample Numbers Sample Ancestry Cohort(s) Phenotype Definitions & Methods Age of Study Participants Participant Follow-up Time Additional Ancestry Description Additional Sample/Cohort Information
2,068 individuals European NR Cases were individuals with alcohol-related cirrhosis. Participants were defined as cases if they fulfilled one of the following criteria: (1) presence of cirrhosis on liver biopsy specimen (Ishak’s fibrosis stage 5 or 6) or (2) unequivocal clinical and laboratory evidence for the presence of cirrhosis as reflected by a combination of (a) abnormal standard liver function tests (serum transaminases, γ-glutamyl transpeptidase, albumin, prothrombin time, international normalized ratio, and platelet count), (b) cirrhosis-related complications, including encephalopathy or ascites, (c) findings on imaging compatible with a diagnosis of cirrhosis (distorted liver surface, ascites, splenomegaly, collateral circulation), and (d) detection of esophageal varices on upper gastrointestinal endoscopy. Phase 2 replication analysis dataset used to select SNPs for GRS. Case/control breakdown not provided.
2,545 individuals European
(British, English, Scottish, Welsh, Irish, German)
UKB Cases were individuals with alcohol-related cirrhosis. For participants from Buch et al's UK cohort cases had evidence of cirrhosis on histologic examination of liver biopsy tissue. From Buch et al's German cohort, participants were defined as cases if they fulfilled one of the following criteria: (1) presence of cirrhosis on liver biopsy specimen (Ishak’s fibrosis stage 5 or 6) or (2) unequivocal clinical and laboratory evidence for the presence of cirrhosis as reflected by a combination of (a) abnormal standard liver function tests (serum transaminases, γ-glutamyl transpeptidase, albumin, prothrombin time, international normalized ratio, and platelet count), (b) cirrhosis-related complications, including encephalopathy or ascites, (c) findings on imaging compatible with a diagnosis of cirrhosis (distorted liver surface, ascites, splenomegaly, collateral circulation), and (d) detection of esophageal varices on upper gastrointestinal endoscopy. Participants from Germany and Switzerland were independently diagnosed as alcohol dependent, according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria by 2 psychiatrists. For the UKB cohort, cases were defined with (a) ≥2 hospital admissions for alcohol-related cirrhosis before or after inclusion in the UKB study, (defined as International Classification of Diseases 10th Revision [ICD 10]: K70.3 in any diagnostic position); or (b) death from alcohol-related cirrhosis (defined as ICD 10: K703 in any cause-of-death position). Phase 1 replication/validation analysis dataset used to obtain weights for each SNP within the GRS. Additional cases and controls were obtained from a UK cohort and a German cohort described by Buch et al (PMID: 26482880). Case/control breakdown not provided.

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM002011 PSS000996|
Ancestry Not Reported|
107,014 individuals
PGP000180 |
Innes H et al. Gastroenterology (2020)
Reported Trait: Incident liver cirrhosis in individuals at-risk for nonalcoholic fatty liver disease (time to first hospitilisation) C-index: 0.62 [0.59, 0.64] Hazard Ratio (HR, top 20% vs bottom 20%): 3.12 [2.37, 4.12]
PPM002012 PSS000996|
Ancestry Not Reported|
107,014 individuals
PGP000180 |
Innes H et al. Gastroenterology (2020)
Reported Trait: Incident liver cirrhosis in individuals at-risk for nonalcoholic fatty liver disease (time to first hospitilisation) Hazard Ratio (HR, top 20% vs bottom 20%): 3.16 [2.38, 4.21] Age, sex, BMI, diabetes, units of alcohol consumed per week
PPM002013 PSS000996|
Ancestry Not Reported|
107,014 individuals
PGP000180 |
Innes H et al. Gastroenterology (2020)
Reported Trait: Incident liver cirrhosis in individuals at-risk for nonalcoholic fatty liver disease (time to first hospitilisation) C-index: 0.677 [0.653, 0.7] Age, sex

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS000996 All individuals (cases and controls) met the at-risk criteria for nonalcoholic fatty liver disease (NAFLD) defined as a BMI ≥30 kg/m2 or diagnosis of type 2 diabetes, or both, without evidence of any other cause of liver disease including excess alcohol . Cases were individuals who had been hospitalised with cirrhosis for the first time. A hospital admission for cirrhosis was defined according to the Ratib et al (PMID: 24419483) validated algorithm incorporating appropriate ICD discharge codes and OPCS Classification of Interventions and Procedures version 4 codes. Mean = 7.9 years
[
  • 562 cases
  • , 106,452 controls
]
,
43.0 % Male samples
Median = 59.0 years
Range = [52.0, 64.0] years
Not reported UKB GRS dataset used to test/ evaluate performance of GRS. The GRS dataset is independent of the discovery analysis datasets containing UKB participants. Possible sample overlap between the GRS dataset and the phase 1 replication/validation analysis and phase 2 replication analysis datasets containing UKB participants.